Technical Scrutiny: Vivus Inc., Sanofi, DENTSPLY Intl., and Acura Pharma
Editor Note: For more information about this release, please scroll to bottom.
LONDON, August 9, 2013
LONDON, August 9, 2013 /PRNewswire/ --
On Thursday August 8, 2013, shares in healthcare companies ended on a higher
note, tracking gains in the broader market. The major movers in the healthcare
sector on Thursday included Vivus Inc. (NASDAQ: VVUS), Sanofi (NYSE: SNY),
DENTSPLY International Inc. (NASDAQ: XRAY), and Acura Pharmaceuticals Inc.
(NASDAQ: ACUR). AAAResearchReports.com tracked VVUS, SNY, XRAY, and ACUR.
These reports can be seen for free at:
Vivus Inc.'s shares moved higher on Thursday, reversing some of their recent
losses. The company's shares ended the day at an intraday high of $14.16, up
0.78% from the previous closing price. A total of 2.16 million shares were
traded, which is below the daily average volume of 2.57 million. The stock is
up 12.92% in the last one month, outperforming the S&P 500 which has gained
3.48% during the same period. Further, the stock is currently trading above
its 50-day and 200-day moving averages. Download free research on VVUS by
signing up now at:
Shares in Sanofi gained 0.98% on Thursday, extending their gains from previous
trading sessions. The company's shares fluctuated between $52.41 and $52.99,
before finishing the day at $52.79. A total of 2.29 million shares were
traded, which is above the daily average volume of 1.21 million. Sanofi's
shares have gained 3.47% in the last three trading sessions, outperforming the
S&P 500 which has declined 0.57% during the same period. Register for today's
free analysis on SNY at:
Shares in DENTSPLY International Inc. closed the day 0.85% higher at $42.76
after oscillating between $42.37 and $42.79. A total of 0.56 million shares
were traded, which is below the daily average volume of 0.85 million. The
company's shares have gained 0.14% in the last three trading sessions and
2.30% in the last one month. A free report on XRAY can be accessed by
Shares in Acura Pharmaceuticals Inc. moved higher on Thursday, tracking gains
in the broader market. The company's shares closed the day up 0.56%, at $1.78,
after oscillating between $1.77 and $1.81. A total of 0.18 million shares were
traded, which is below the daily average volume of 0.48 million. In the last
three months, the stock has lost 17.59%, underperforming the S&P 500 which has
gained 3.97% in the same period. Further, the stock is trading below its
50-day and 200-day moving averages. Register with AAA Research Reports and
download research on ACUR for free at:
1.This is not company news. We are an independent source and our views do
not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
basis and reviewed by a CFA ® charterholder. However, we are only human
and are prone to make mistakes. If you notice any errors or omissions,
please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
increase awareness for mentioned companies to our subscriber base and the
4.If you wish to have your company covered in more detail by our team, or
wish to learn more about our services, please contact us at
5.For any urgent concerns or inquiries, please contact us at
6.Are you a public company? Would you like to see similar coverage on your
company? Send us a full investors' package to
research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.
SOURCE AAA Research Reports
Contact: Phone #: + 1-(646)-396-9126
Press spacebar to pause and continue. Press esc to stop.